Intelligence Profile
Clinical Applications
Testosterone undecanoate is primarily used for testosterone replacement therapy in men with hypogonadism (testosterone deficiency). The available evidence demonstrates its clinical applications across several key areas:
Primary Hypogonadism Treatment
Clinical trials indicate testosterone undecanoate has been extensively studied for treating adult-onset testosterone deficiency. A completed Phase 3 trial (NCT03198728) specifically evaluated the efficacy and safety of oral testosterone undecanoate in hypogonadal men, with additional follow-up studies (NCT01699178) providing longer-term safety and efficacy data. Pharmacokinetic studies have established dosing protocols and steady-state characteristics for oral formulations.
Delayed Puberty in Adolescents
Research shows testosterone therapy, including testosterone undecanoate, is used to promote puberty in boys with constitutional delay of growth and puberty. A 2026 systematic review and meta-analysis found that low-dose testosterone treatment improved wellbeing and emotional state in boys with self-limited delayed puberty, suggesting clinical benefits beyond physical development.
Specialized Medical Conditions
Emerging applications include:
Muscle Wasting in Liver Disease: A 2026 trial investigated testosterone addition to nutrition and exercise programs for muscle mass improvement in men with cirrhosis, addressing muscle wasting complications in chronic liver disease.
Spinal Cord Injury: Research demonstrates testosterone-augmented multimodal exercise interventions may benefit patients with spinal cord injury. An active Phase 2 trial (NCT04460872) is examining locomotor training combined with testosterone to promote bone and muscle health in this population.
Gender-Affirming Therapy
Limited evidence suggests testosterone undecanoate use in transgender patients, though a 2026 case report documented cerebral venous sinus thrombosis as a potential serious adverse event in this context.
Clinical Considerations
The evidence base includes guidance on best practices for oral testosterone undecanoate use, with research into urinary proteomic signatures for monitoring exogenous testosterone exposure. Studies also suggest that testosterone therapy may influence mortality outcomes in men with age-related testosterone deficiency, though the clinical significance requires further investigation.
Disclaimer: This information is for educational purposes only and should not replace professional medical advice. Treatment decisions should always be made in consultation with qualified healthcare providers who can assess individual patient circumstances.